GlassScriptPhysician profile
Olga Nilova
NPI 1730236084
$1,248.85
in general payments reported to CMS, 2019-2025
21 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $11.29 · 2021: $133 · 2022: $262 · 2023: $284 · 2024: $143 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $311.46 | 2019-2024 | Jornay Pm |
| Tris Pharma INC | $162.54 | 2019-2025 | Dyanavel Xr |
| Pfizer INC. | $154.45 | 2019-2025 | |
| Sanofi Pasteur INC. | $143.29 | 2019-2025 | |
| Cranial Technologies, INC | $131.99 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $60.56 | 2022-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Photonicare INC | $30.81 | 2025 | Otosight Middle Ear Scope |
| Alexion Pharmaceuticals, INC. | $30.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.59 | 2023 | Flumist Quadrivalent |
| Corium, LLC | $21.78 | 2022 | |
| Shire North American Group INC | $21.07 | 2019 | |
| Aytu Biopharma, INC. | $18.44 | 2025 | |
| Vertical Pharmaceuticals, LLC | $17.83 | 2024 | Relexxii |
| Seqirus USA INC | $17.14 | 2021 | |
| Adlon Therapeutics L.P. | $16.78 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15.85 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.90 | 2021 | |
| Glaxosmithkline, LLC. | $14.50 | 2019 | |
| Collegium Pharmaceutical, INC. | $14.48 | 2025 | Jornay Pm |
| Kowa Pharmaceuticals America, INC. | $14.43 | 2024 | Zoryve |
| Neos Therapeutics, LP | $12.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Nilova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.